Factors predicting prostate specific antigen testing first-degree relatives of prostate cancer patients

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 5, 2004, Pages 753-758

  Vadaparampil, Susan Thomas ^a   Jacobsen, Paul B ^a   Kash, Kathryn ^b   Watson, Iryna S ^a   Saloup, Raoul ^c   Pow Sang, Julio ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; CANCER RISK; CANCER SCREENING; CONSENSUS; DECISION MAKING; DISEASE SEVERITY; HIGH RISK POPULATION; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; RISK ASSESSMENT;

AGE DISTRIBUTION; AGED; ATTITUDE TO HEALTH; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PEDIGREE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 2942552244     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ACS, Cancer facts and figures-2003. (ACS Publication No. 5008.03). Atlanta, GA: American Cancer Society; 2003.
2. Ferrini R, Woolf SH. American College of Preventive Medicine practice policy. Screening for prostate cancer in American men. Am J Prev Med 1998;15(1):81-4.
3. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137(11):917-29.
4. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Huntingt) 2000;14(2): 267-72, 277-8, 280 passim.
5. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003;53(1):27-43.
6. Close DR, Kristal AR, Li S, Patterson RE, White E. Associations of demographic and health-related characteristics with prostate cancer screening in Washington State. Cancer Epidemiol Biomark Prev 1998;7(7):627-30.
7. McDavid K, Melnik TA, Derderian H. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997. Prev Med 2000;31(3):195-202.
8. Miller SM, Diefenbach MA, Kruus LK, et al. Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med 2001;24(3):247-58.
9. Taylor KL, Di Placido J, Redd WH, et al. Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants. Cancer 1999;85(6):1305-12.
10. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. Urology 1997;50(3):360-5.
11. Bratt O, Damber JE, Emanuelsson M, et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 2000;36(2):235-41.
12. Cormier L, Reid K, Kwan L, Litwin MS. Screening behavior in brothers and sons of men with prostate cancer. J Urol 2003;169(5):1715-9.
13. Van der Velde FW, Van der Pligt J. AIDS-related health behavior: coping, protection motivation, and previous behavior. J Behav Med 1991;14(5):429-51.
14. Rippetoe PA, Rogers RW. Effects of components of protection-motivation theory on adaptive and maladaptive coping with a health threat. J Pers Soc Psychol 1987;52(3):596-604.
15. Runge C, Prentice-Dunn S, Scogin F. Protection motivation theory and alcohol use attitudes among older adults. Psychol Rep 1993;73(1):96-8.
16. Plotnikoff R, Higginbotham N. Predicting low-fat diet intentions and behaviors for the prevention of coronary heart disease: an application of Protection Motivation Theory among an Australian population. Psychol Health 1995;10(5):397-408.
17. Eppright D, Tanner J, Hunt J. Knowledge of the Ordered Protection Motivation Model: tools for preventing AIDS. J Bus Res 1994;30:13-24.
18. Aspinwall LG, Kemeny ME, Taylor SE, Schneider SG, Dudley JP. Psychosocial predictors of gay men's AIDS risk-reduction behavior. Health Psychol 1991;10(6):432-44.
19. Brouwers M, Sorrentino R. Uncertainty orientation and Protection Motivation Theory: the role of individual differences in health compliance. J Pers Soc Psychol 1993;65(1):102-112.
20. Rogers RW. A protection motivation theory of fear appeals and attitude change. J Psych 1975;91:93-114.
21. Maddux J, Rogers RW. Protection motivation theory and self-efficacy: a revised theory of fear appeals and attitude change. J Exp Soc Psychol 1983;19:469-79.
22. Prentice-Dunn S, Rogers RW. Protection Motivation Theory and preventive health: beyond the Health Belief Model. Health Educ Res 1986;1(3):153-61.
23. Champion VL, Scott CR. Reliability and validity of breast cancer screening belief scales in African American women. Nurs Res 1997;46:331-7.
24. Stein JA, Fox SA, Murata PJ, Morisky DE. Mammography usage and the health belief model. Health Educ Q 1992;19(4):447-62.
25. Holm CJ, Frank DI, Curtin J. Health beliefs, health locus of control, and women's mammography behavior. Cancer Nurs 1999;22(2):149-56.
26. Aiken LS, West SG, Woodward CK, Reno RR. Health beliefs and compliance with mammography-screening recommendations in asymptomatic women. Health Psychol 1994;13(2):122-9.
27. Champion VL. Instrument development for health belief model constructs. ANS Adv Nurs Sci 1984;6(3):73-85.
28. Myers RE, Wolf TA, McKee L, et al. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer 1996;78(3):471-9.
29. Kurtz ME, Given B, Given CW, Kurtz JC. Relationships of barriers and facilitators to breast self-examination, mammography, and clinical breast examination in a worksite population. Cancer Nurs 1993;16:251-9.
30. Champion V. The relationship of selected variables to breast cancer detection behaviors in women 35 and older. Oncol Nurs Forum 1991;18:733-9.
31. Curry SJ, Emmons KM. Theoretical models for predicting and improving compliance with breast cancer screening. Ann Behav Med 1994;16:302-16.
32. Steffen VJ. Men's motivation to perform the testicular self-exam: effects of prior knowledge and an educational brochure. J Appl Soc Psychol 1990;20:681-702.
33. Little RC, Milliken GA, Stroup WW, et al. Sas Systems for Mixed Models. Cary, NC: Sas Institute; 1996.
34. Miesfeldt S, Jones SM, Cohn W, et al. Men's attitudes regarding genetic testing for hereditary prostate cancer risk. Urology 2000;55(1):46-50.
35. Arar N, Thompsen I, Sarosdy M, et al. Risk perceptions among patients and their relatives regarding prostate cancer and its heredity. Prostate Cancer Prostatic Dis 2000;3(3):176-85.
36. Steele CB, Mille DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 2000;90(10):1595-600.
37. Eisen SA, Waterman B, Skinner CS, et al. Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Urology 1999;53(3):516-22.
38. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97(6):1528-40.
39. Drossaert CC, Boer H, Seydel ER. Perceived risk, anxiety, mammogram uptake, and breast self-examination of women with a family history of breast cancer: the role of knowing to be at increased risk. Cancer Detect Prev 1996;20(1):76-85.
40. Hailey BJ, Carter CL, Burnett DR. Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer. Health Care Women Int 2000;21(8):701-15.
41. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr 1994;(16):171-6.
42. Royak-Schaler R, Klabunde CN, Greene WF, et al. Communicating breast cancer risk: patient perceptions of provider discussions. Medscape Women's Health 2002;7(2):2.
43. Myers RE, Hyslop T, Jennings-Dozier K, et al. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomark Prev 2000;9(12):1323-8.
44. Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med 1990;19(3):279-90.
45. Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84(1):24-30.
46. Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs 1995;18(5):385-92.
47. Melamed S, Rabinowitz S, Feiner M, Weisberg E, Ribak J. Usefulness of the protection motivation theory in explaining hearing protection device use among male industrial workers. Health Psychol 1996;15(3):209-15.
48. Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med 2002;113(8):663-7.
49. Chan EC, Vernon SW, O'Donnell FT, et al. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health 2003;93(5):779-85.
50. Flood AB, Wennberg JE, Nease RF, et al. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med 1996;11(6):342-9.
51. Wolf AM, Nasser JF, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med 1996;156(12):1333-6.
52. Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients' self-reports regarding prostate cancer screening. Prev Med 1999;28(3):297-303.